BioSmart Statistics

Total Valuation

BioSmart has a market cap or net worth of KRW 85.30 billion. The enterprise value is 159.24 billion.

Market Cap	85.30B
Enterprise Value	159.24B

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

BioSmart has 25.27 million shares outstanding. The number of shares has decreased by -10.80% in one year.

Current Share Class	25.27M
Shares Outstanding	25.27M
Shares Change (YoY)	-10.80%
Shares Change (QoQ)	-1.24%
Owned by Insiders (%)	24.78%
Owned by Institutions (%)	0.21%
Float	18.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.18
PB Ratio	0.53
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	15.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.35, with an EV/FCF ratio of -104.41.

EV / Earnings	-72.10
EV / Sales	0.33
EV / EBITDA	5.35
EV / EBIT	7.32
EV / FCF	-104.41

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.43.

Current Ratio	1.79
Quick Ratio	0.90
Debt / Equity	0.43
Debt / EBITDA	2.43
Debt / FCF	-45.75
Interest Coverage	4.93

Financial Efficiency

Return on equity (ROE) is -0.68% and return on invested capital (ROIC) is 5.83%.

Return on Equity (ROE)	-0.68%
Return on Assets (ROA)	4.87%
Return on Invested Capital (ROIC)	5.83%
Return on Capital Employed (ROCE)	10.90%
Revenue Per Employee	2.99B
Profits Per Employee	-13.80M
Employee Count	160
Asset Turnover	1.80
Inventory Turnover	7.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.56% in the last 52 weeks. The beta is 1.06, so BioSmart's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-36.56%
50-Day Moving Average	3,319.40
200-Day Moving Average	3,403.33
Relative Strength Index (RSI)	44.43
Average Volume (20 Days)	1,287,572

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSmart had revenue of KRW 477.90 billion and -2.21 billion in losses. Loss per share was -92.46.

Revenue	477.90B
Gross Profit	84.22B
Operating Income	20.66B
Pretax Income	7.26B
Net Income	-2.21B
EBITDA	28.69B
EBIT	20.66B
Loss Per Share	-92.46

Full Income Statement

Balance Sheet

The company has 25.42 billion in cash and 69.78 billion in debt, giving a net cash position of -44.36 billion or -1,754.97 per share.

Cash & Cash Equivalents	25.42B
Total Debt	69.78B
Net Cash	-44.36B
Net Cash Per Share	-1,754.97
Equity (Book Value)	161.15B
Book Value Per Share	5,215.78
Working Capital	61.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.56 billion and capital expenditures -7.09 billion, giving a free cash flow of -1.53 billion.

Operating Cash Flow	5.56B
Capital Expenditures	-7.09B
Free Cash Flow	-1.53B
FCF Per Share	-60.34

Full Cash Flow Statement

Margins

Gross margin is 17.62%, with operating and profit margins of 4.32% and -0.46%.

Gross Margin	17.62%
Operating Margin	4.32%
Pretax Margin	1.52%
Profit Margin	-0.46%
EBITDA Margin	6.00%
EBIT Margin	4.32%
FCF Margin	n/a

Dividends & Yields

BioSmart does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	10.80%
Shareholder Yield	n/a
Earnings Yield	-2.59%
FCF Yield	-1.79%

Stock Splits

The last stock split was on September 20, 2010. It was a reverse split with a ratio of 0.16667.

Last Split Date	Sep 20, 2010
Split Type	Reverse
Split Ratio	0.16667

Scores

BioSmart has an Altman Z-Score of 3.1.

Altman Z-Score	3.1
Piotroski F-Score	n/a